Bellicum Pharmaceuticals, Inc.
PSCA CAR-T CELLS

Last updated:

Abstract:

The technology relates generally to the field of immunology and relates in part to T cell compositions and methods for treating diseases and disorders associated with the presence of tumor cells that express prostate stem cell antigen.

Status:
Application
Type:

Utility

Filling date:

12 Dec 2019

Issue date:

3 Mar 2022